文献速递心境障碍会诊联络精神医学

双相障碍患者肾功能下降与锂盐治疗:瑞典北部LiSIE与MONICA队列研究

Kidney function in patients with bipolar disorder with and without lithium treatment compared with the general population in northern Sweden: results from the LiSIE and MONICA cohorts.
PubMed 文献 · Lancet Psychiatry · 2022-09-12

该研究比较瑞典北部双相或分裂情感性障碍患者与一般人群的估算肾小球滤过率(eGFR)年龄相关下降速度。锂治疗超过10年后下降显著陡于所有其他组。

要点

  • 锂治疗超过10年后eGFR下降速度显著快于所有其他组及一般人群。
  • 锂盐对eGFR的影响存在高度个体间差异,需权衡精神健康与肾脏健康。

核心结论

  • 双相或分裂情感性障碍患者更陡的eGFR下降可归因于锂盐,但肾功能下降轨迹个体差异很大。
  • 影响肾脏的共病应积极治疗,可能有助于改变肾功能下降轨迹。
  • 对于肾功能快速下降的患者,需在继续锂盐治疗精神疾病与为肾脏健康停用锂盐之间进行权衡。

研究设计与样本

  • 主要结局为基于肌酐的eGFR年龄相关下降,采用线性回归评估,校正性别并按锂暴露时长分组(从未或<1年、1-5年、>5-10年、>10年)。
  • 未收集种族数据。

主要发现

  • 锂肾病被判定为中度至重度慢性肾病最常见原因,但共病也起作用。
  • 锂盐对eGFR的影响显示高度个体间变异。

临床怎么用

  • 对使用锂盐的双相障碍患者应监测eGFR变化轨迹,尤其关注锂治疗超过10年者。
  • 应积极治疗影响肾脏的共病,作为可能改变肾功能下降轨迹的手段之一。
  • 对肾功能快速下降的患者,需个体化权衡继续锂盐治疗精神疾病与停用锂盐保护肾脏健康的利弊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The clinical relevance of lithium nephropathy is subject to debate. Kidney function decreases with age and comorbidities, and this decline might lead to attribution bias when erroneously ascribed to lithium. We aimed to investigate whether patients with bipolar or schizoaffective disorder had faster decline in estimated glomerular filtration rate (eGFR) compared with the general population, whether observed differences in the steepness of the decline were attributable to lithium, and whether such changes depended on the length of lithium exposure. METHODS: In this cross-sectional cohort study, we used clinical data from the Lithium-Study into Effects and Side-effects (LiSIE) retrospective cohort study, which included patients with bipolar disorder or schizoaffective disorder whose medical records were reviewed up to Dec 31, 2017, and the WHO Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) study, covering a representative sample of the general population in northern Sweden aged 25-74 years. The primary outcome was the age-associated decline of creatinine-based eGFR, assessed using linear regression. We adjusted for sex and grouped for different lengths of lithium exposure (never or <1 year, 1-5 years, >5-10 years, and >10 years). For patients with moderate-to-severe kidney disease we identified the underlying nephropathy in the case records. FINDINGS: From LiSIE, we included 785 patients (498 [63%] female and 287 [37%] male), with a mean age of 49·8 years (SD 13·2; range 25-74). From MONICA, we included 1549 individuals (800 [52%] female and 749 [48%] male), with a mean age of 51·9 years (13·8; 25-74). No ethnicity data were collected. Adjusted for duration of lithium exposure, eGFR declined by 0·57 mL/min/1·73 m2/year (95% CI 0·50-0·63) in patients with bipolar disorder or schizoaffective disorder and by 0·57 mL/min/1·73 m2/year (0·53-0·61) in the reference population. Lithium added 0·54 mL/min/1·73 m2 (0·43-0·64) per year of treatment (p<0·0001). After more than 10 years on lithium, decline was significantly steeper than in all other groups including the reference population (p<0·0001). Lithium nephropathy was judged to be the commonest cause of moderate-to-severe chronic kidney disease, but comorbidities played a role. The effect of lithium on eGFR showed a high degree of inter-individual variation. INTERPRETATION: Steeper eGFR decline in patients with bipolar disorder or schizoaffective disorder can be attributed to lithium, but the trajectory of kidney function decline varies widely. Comorbidities affecting kidneys should be treated assertively as one possible means to affect the trajectory. In patients with a fast trajectory, a trade-off is required between continuing lithium to treat mental health problems and discontinuing lithium for the sake of renal health. FUNDING: Norrbotten County Research and Learning Fund Sweden, Visare Norr (Northern County Councils Regional Federation Fund), Swedish Kidney Foundation (Njurfonden), Swedish Kidney Association (Njurförbundet), Norrbotten section. TRANSLATION: For the Swedish translation of the Summary see Supplementary Materials section.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Fransson F, Werneke U, Harju V, et al. Kidney function in patients with bipolar disorder with and without lithium treatment compared with the general population in northern Sweden: results from the LiSIE and MONICA cohorts. Lancet Psychiatry. 2022. PMID: 36108668. doi:10.1016/S2215-0366(22)00265-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。